Japan Medical Dynamic Marketing, Inc.
613.00
JPY
-1.00
(-0.16%)
ISIN
JP3689100000
Return %
Stock
S&P 500
1Y
16.54
14.20
3Y
-14.15
81.12
5Y
-71.75
68.34
Capital Structure
JPY
•
in mil. unless spec.Working Capital
JPY
•
in mil. unless spec.Growth Rates
JPY
•
in mil. unless spec.Quarterly Revenue
JPY
•
in mil. unless spec.Quarterly Earnings Per Share
JPY
•
in mil. unless spec.Quarterly Dividends Per Share
JPY
•
in mil. unless spec.Company Description
- CEO
- Toshiyuki Hironaka
- Full Time Employees
- 539
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- 12-2, Ichigayadaimachi Tokyo TY Japan 162-0066
- IPO Date
- Mar 24, 2000
- Website
- jmdm.co.jp
- Similar Companies
- Business
- Japan Medical Dynamic Marketing, Inc. engages in the development, manufacture, import, and sale of advanced medical equipment primarily for orthopedic surgery. Its core product offerings include trauma devices, joint prostheses, spinal fixation devices, and artificial bone fillers. The company supplies its products mainly to medical professionals and major hospitals across Japan, operating through its Japan segment, which imports and sells materials for osteosynthesis, artificial joints, and spinal fixation devices. Additionally, its America segment handles the development, manufacture, and sales of these medical products in North America. Founded in 1973 and headquartered in Tokyo, Japan, Japan Medical Dynamic Marketing is recognized as a leading company in the Japanese orthopedic medical device market. Recent strategic changes include a significant organizational restructuring to a business division system as of April 1, 2024, designed to strengthen the sales structure. The company has introduced the Trivicta Hip Stem, a new artificial hip joint product, to boost growth in the hip joint segment. Procurement shifts occurred with some key products sourcing moving from the U.S. to Japan to mitigate exchange rate risks and reduce costs. Furthermore, Japan Medical Dynamic Marketing began supplying its BKS TriMax medical instruments to the U.S. market starting February 2024. These moves reflect the company's efforts to enhance procurement capabilities, expand product offerings, and increase its presence in both domestic and international markets. Japan Medical Dynamic Marketing operates mainly in the healthcare industry, focusing on the medical device segment associated with orthopedic surgery. Its target market comprises hospitals, orthopedic surgeons, and healthcare providers in Japan and the U.S. The company also leverages its dual role as a manufacturer and a trading company to offer a comprehensive product range and respond flexibly to dynamic market needs. Its subsidiary operations support these activities in North America as part of its expansion and product development strategy. The company’s longstanding presence since its founding and continuous innovation in product development underscores its commitment to contributing to medical care and advancing orthopedic treatment technologies.